We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2222:TADAWULSaudi Arabian Oil Co. Analysis

Data as of 2026-05-27 - not real-time

HK$0.62

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Price action: NVC International is trading at HK$0.62, just above the computed support of HK$0.60 and below the 20‑day SMA of HK$0.6255, indicating limited upside in the near term. The 50‑day and 200‑day SMAs sit higher (HK$0.646 and HK$0.706), reinforcing a bearish trend, while the RSI of 44 suggests the stock is not yet oversold. Technical signals are mixed – a bullish MACD histogram (+0.0002) hints at a possible short‑term reversal, but volume is on a decreasing trajectory and 30‑day volatility is elevated at 33.7%, flagging price instability.
Valuation & fundamentals: The stock trades at a PE of 3.44 and an astonishingly low PB of 0.08, far below the DCF‑derived fair value of HK$0.79, implying a substantial discount. However, revenue fell 2% YoY, operating margin is slightly negative (‑0.23%), and ROE is only 2.6%, indicating weak earnings momentum. The balance sheet is cash‑rich (HK$176 M) with modest debt (HK$18.5 M) but a high debt‑to‑equity ratio of 3.9, and the company does not pay a dividend. Overall, the stock appears undervalued but burdened by thin profitability and cyclical industry exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with limited upside
  • Decreasing volume and high short‑term volatility
  • Mixed technical signals (bullish MACD vs bearish SMAs)

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Strong cash position providing financial flexibility
  • Potential recovery if operating margins improve

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Cyclical consumer‑cyclical sector exposure
  • Geographic diversification across China, US, Europe
  • Low dividend yield and modest long‑term growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-2.00%
Profit Margin5.35%
P/E Ratio3.4
ROE2.62%
ROA0.62%
Debt/Equity3.90
P/B Ratio0.1
Op. Cash FlowHK$25.5M
Free Cash FlowHK$18.7M

Technical Analysis

TrendBearish
RSI44.0
SupportHK$0.60
ResistanceHK$0.67
MA 20HK$0.63
MA 50HK$0.65
MA 200HK$0.71
MACDBullish
VolumeDecreasing
Fear & Greed Index91.05

Valuation

Fair ValueHK$0.79
GradeUndervalued
TypeValue

Risk Assessment

Beta0.25
Volatility33.74%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.